The University of California San Francisco tapped pathology software company Proscia to jointly develop and test artificial intelligence solutions that could improve physicians’ speed and accuracy in diagnosing prostate cancer.
The University of California San Francisco tapped pathology software company Proscia to jointly develop and test artificial intelligence solutions that could improve physicians’ speed and accuracy in diagnosing prostate cancer.